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ABSTRACT: Introduction: The Finnish Diabetes Risk Score (FINDRISC) is a tool that was initially developed to 
predict the risk of  developing type 2 diabetes mellitus in adults. This tool is simple, quick to apply, non-invasive, 
and low-cost. The aims of  this study were to perform a translation and cultural adaptation of  the original version 
of  FINDRISC into Brazilian Portuguese and to assess test-retest reliability. Methodology: This work was done 
following the ISPOR Principles of  Good Practice for the Translation and Cultural Adaptation Process for Patient-
Reported Outcomes Measures. Once the final Brazilian Portuguese version (FINDRISC-Br) was developed, the 
reliability assessment was performed using a non-random sample of  83 individuals attending a primary care 
health center. Each participant was interviewed by trained registered dieticians on two occasions with a mean 
interval of  14 days. The reliability assessment was performed by analyzing the level of  agreement between the 
test-retest responses of  FINDRISC-Br using Cohen’s kappa coefficient and the intraclass correlation coefficient 
(ICC). Results: The steps of  ISPOR guidelines were consecutively followed without major problems. Regarding 
the reliability assessment, the questionnaire as a whole presented adequate reliability (Cohen’s kappa = 0.82, 
95%CI 0.72 – 0.92 and ICC = 0.94, 95%CI 0.91 – 0.96). Conclusion: FINDRISC was translated into Brazilian 
Portuguese and culturally adapted following standard procedures. FINDRISC-Br has thus become available 
for use and has potential as a screening tool in different Brazilian settings and applications.
Keywords: Diabetes mellitus. Screening. Translating. Brazil. Reproducibility of  results.
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INTRODUCTION
The Finnish Diabetes Risk Score (FINDRISC) is a tool developed by Finnish researchers to 
predict the risk of  developing type 2 diabetes mellitus (T2DM) within ten years among adults 
aged 35–64 years1-3. FINDRISC is one of  the most commonly used questionnaires to identify 
people at high risk for T2DM in different populations of  the world4-8 and has several advantages 
over other risk scores9,10. Other than predicting the risk of  T2DM, it has also been shown to 
detect undiagnosed T2DM11,12 and hepatic steatosis13 and to predict drug-treated hypertension, 
cardiovascular events, and total mortality14,15. FINDRISC is composed of  eight parameters: 
age, body mass index, waist circumference, physical activity, diet (fruit, vegetable, and berry 
consumption), personal history of  antihypertensive drug use, personal history of  hyperglyce-
mia (including previous gestational diabetes), and family history of  diabetes. Each response is 
scored according to associated risk, with a final sum score range of  0–26 points1,2.
The FINDRISC questionnaire has been applied previously in some studies in Brazil13,16-19. 
However, they used a simple translation of  the original tool, not following standard proce-
dures. Therefore, we decided to produce a new Brazilian Portuguese version of  FINDRISC 
in accordance with standard procedures, intending to contribute to an increasing use of  
more reliable tools. In this paper, we report the process of  translation and cross-cultural 
adaptation of  the original version of  FINDRISC into Brazilian Portuguese, and its test-re-
test reliability assessment.
RESUMO: Introdução: O Escore Finlandês de Risco de Diabetes (FINDRISC) é um instrumento que inicialmente foi 
desenvolvido para predizer o risco de desenvolver diabetes mellitus tipo 2 em adultos. Esse instrumento é simples, 
rápido de aplicar, não invasivo e de baixo custo. Os objetivos deste estudo foram descrever o processo de tradução 
e adaptação transcultural do FINDRISC para o português do Brasil e avaliar a sua confiabilidade teste-reteste. 
Metodologia: O projeto foi conduzido de acordo com as recomendações dos Princípios de Boas Práticas para o 
Processo de Tradução e Adaptação Transcultural de Medidas de Resultados Relatados pelo Paciente desenvolvidas 
pela ISPOR. Uma vez desenvolvida a versão final em português brasileiro (FINDRISC-Br), realizou-se a avaliação 
da confiabilidade usando uma amostra não aleatória de 83 indivíduos atendidos em uma unidade de atenção 
básica. Cada participante foi entrevistado por nutricionistas registradas treinadas em duas ocasiões com intervalo 
médio de 14 dias. A avaliação da confiabilidade foi realizada por meio da análise do nível de concordância entre 
as respostas do teste-reteste, utilizando-se o coeficiente kappa de Cohen e o coeficiente de correlação intraclasse 
(CCI). Resultados: As etapas das diretrizes da ISPOR foram seguidas consecutivamente sem maiores problemas. 
Em relação à avaliação da confiabilidade do teste-reteste, o questionário como um todo apresentou confiabilidade 
adequada (kappa de Cohen = 0,82; IC95% 0,72 – 0,92 e CCI = 0,94; IC95% 0,91 – 0,96). Conclusão: O FINDRISC 
foi traduzido e adaptado transculturalmente para o português do Brasil seguindo procedimentos padronizados. 
O FINDRISC-Br já está disponível para uso e tem potencial para ser usado como ferramenta de rastreamento em 
diferentes cenários brasileiros.
Palavras-chave: Diabetes mellitus. Rastreamento. Tradução. Brasil. Reprodutibilidade dos testes.
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METHODOLOGY
SETTING AND SUBJECTS
This study took place in a primary care health center managed by the Botucatu 
Medical School of  Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP). 
This center serves a population of  more than 40,000 inhabitants, corresponding to 30% 
of  the population in Botucatu, State of  São Paulo, Brazil. Individuals aged 18 years 
or older were invited to participate in the study as they were waiting for an appoint-
ment at the primary care health center. Those with cognitive problems and/or with a 
previous diagnosis of  DM were not included. This study was performed between July 
and September of  2017. Interviews were conducted in two stages, from Monday to 
Friday, in the mornings and afternoons, with an average of  6 to 7 subjects interviewed 
sequentially. The first stage (test) involved the following procedures: inviting subjects 
to participate in the study; assessing the eligibility criteria; explaining to subjects the 
two stages of  the study; reading and signing by the subjects of  the informed consent 
form; anthropometric measurements; applying the questionnaire; and scheduling the 
second interview. The second stage (retest) involved: anthropometric measurements 
and application of  the questionnaire.
The interviews were performed in a consulting room by three registered dieticians, who 
also performed the anthropometric measurements. Bodyweight and height were measured 
with minimal clothing and bare feet, using a scale with a coupled stadiometer (MIC-200PPA, 
Micheletti, São Paulo, Brazil). Standing height was measured with the head positioned in 
the Frankfurt plane. Waist circumference was measured using a measuring tape at the level 
of  the navel. Body mass index (BMI) was calculated as body weight in kilograms divided 
body height in meters squared.
The interviewers were trained before the application of  the questionnaire. The train-
ing program consisted of  two sessions. In the first session, the questionnaire was read, the 
interviewers were provided with an overview of  the anthropometric measurements, and 
doubts were clarified. The second session was to test and train the interviewers. In this ses-
sion, the interviewers conducted ten mock interviews, while the instructor (E. M. B.) pro-
vided corrective feedback.
The research protocol was submitted to and approved by the Human Research Ethics 
Committee of  the Botucatu Medical School of  UNESP (approval number 1,357,626) and 
written informed consent was obtained from all subjects.
TRANSLATION AND CULTURAL ADAPTATION
The translation and cultural adaptation process were conducted following the recommended 
principles of  good practice for the translation and cultural adaptation for patient-reported 
BARIM, E.M. ET AL.
4
REV BRAS EPIDEMIOL 2020; 23: E200060
outcomes measures developed by the International Society for Pharmacoeconomics and 
Outcomes Research (ISPOR) Task Force20. According to the ISPOR guidelines the process 
consists of  ten steps: 
1. Preparation; 
2. Forward translation; 
3. Reconciliation; 
4. Back translation; 
5. Back translation review; 
6. Harmonization; 
7. Cognitive Debriefing; 
8. Review of  cognitive debriefing results and finalization; 
9. Proofreading; 
10. Final report. 
In our case, eight steps were followed. We did not include Step 6. Harmonization, since it 
is used for cross-cultural adaptations of  the same instrument for multiple languages at the 
same time. Further, Step 7. Cognitive debriefing and Step 8. Review of  cognitive debriefing results 
and finalization were unified in a single step named Understanding.
TEST-RETEST RELIABILITY
After producing the final Brazilian Portuguese version of  FINDRISC (FINDRISC-Br), 
the test-retest reliability of  the tool was assessed following Mokkink et al.21. To estab-
lish the test-retest reliability of  FINDRISC-Br, the level of  agreement between the test-re-
test responses of  FINDRISC-Br was checked. The average interval between the first and 
second interviews was two weeks22,23. Cohen’s kappa coefficients24 and intraclass correla-
tion coefficients (ICC)25 and their 95% confidence intervals (95%CI) were estimated. Both 
coefficients were calculated for each item of  the FINDRISC questionnaire and further for 
the FINDRISC total score. We considered good reliability when kappa and ICC estimates 
were > 0.80 and > 0.75, respectively24,25. Statistical analysis was performed with the software 
package SAS 9.4 (SAS Institute, Inc., Cary, NC, USA).
RESULTS
TRANSLATION AND CULTURAL ADAPTATION
Figure 1 summarizes the different steps in the translation and cultural adaptation pro-
cess of  FINDRISC.
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Figure 1. Flow diagram of the steps taken in the process of translation and cross-cultural 
adaptation of the Finnish Diabetes Risk Score (FINDRISC), according to the International Society 
for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines.
Step 1 - Preparation
Agreement and consent from the authors to use the FINDRISC questionnaire
Step 2 - Forward Translation
Translation of FINDRISC from the original version in English into Brazilian Portuguese
Translation 1 Translation 2 Translation 3 Translation 4
Step 3 - Reconciliation
Analysis of the four Brazilian Portuguese versions by an expert committee 
and production of a Synthesis version of translations
Step 4 - Back-Translation
Back translation of the Synthesis version of translations from Portuguese into English
Back-translation 1 Back-translation 2
Step 5 - Back-Translation Review
Back-translations were compared with the original English by the 
original authors of the FINDRISC and the expert committee. 
A Synthesis version of reverse translations was created
Step 6 - Understanding
The Synthesis version of reverse translations was field-tested among health professionals 
and patients of a primary care health center to assess the appropriate understanding 
of each question and the questionnaire as a whole. A final version was created
Step 7 - Proofreading
Final quality control of the cross-culturally adapted instrument 
and layout of the Brazilian Portuguese version (FINDRISC-Br)
Step 8 - Final Report
Detailed description of all steps and decisions taken in the process 
of translation and cross-cultural adaptation of FINDRISC
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Step 1: preparation
Translation to Brazilian Portuguese of  FINDRISC began after obtaining permission from 
the original authors, Dr. Jaana Lindström and Dr. Jaako Tuomilehto.
Step 2: direct translation
Four independent FINDRISC translations were obtained, from the original version 
in English into Brazilian Portuguese. Two versions were carried out by two professional 
bilingual translators whose first language was Brazilian Portuguese, fluent in English and 
resident in Brazil. A third version had been performed previously by some of  the present 
authors, R.S.R. and J.A.M.C., who used it to screen hepatic steatosis13. The fourth version 
was produced by coauthor K.C.P.M., a registered dietician with experience in public health 
and fluent in English.
Step 3: reconciliation
An expert committee analyzed the four Brazilian Portuguese versions and produced a 
Synthesis Version of  Translations adapting the terms to the culture of  the target population. 
The expert committee was formed by three physicians and two registered dieticians with 
experience in public health or internal medicine, and also by one of  the professional bilin-
gual translators that participated in Step 2.
Step 4: back translation
The Synthesis Version of  Translations was then back-translated into English by two other 
independent professional translators. Both translators were native English speakers and 
fluent in Brazilian Portuguese with no previous knowledge of  the original version of  
FINDRISC in English.
Step 5: back-translation review
The authors of  FINDRISC and the expert committee compared both back-translations 
with the original English version, looking for discrepancies. In this process, the semantic, 
idiomatic, experiential, and conceptual equivalences between versions were assessed26, and 
a Synthesis version of  reverse translations was created.
TRANSLATION AND ADAPTATION OF FINSRISC FORM
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Step 6: understanding
The Synthesis version of  reverse translations was field-tested on 17 health professionals (phy-
sicians, dieticians, nurses, and nursing technicians) and 15 subjects from the same primary 
care health center to check whether every question and the questionnaire as a whole were 
adequately understood. A Likert-type scale was used with the guiding question ‘Do you 
understand what was asked?’. Scores ranged from 0 (‘I did not understand anything’) to 5 
(‘I understood perfectly and have no doubts’). Values ≥ 3 were taken as an indication of  sat-
isfactory comprehension27. The interviewer simply read each item and recorded its score. 
Results showed 100% comprehension of  FINDRISC-Br by health professionals and sub-
jects alike. No adjustments being needed, this Brazilian Portuguese version became final.
Step 7: proofreading
Final review of  FINDRISC’s translation and cross-cultural adaptation was carried out. 
The text of  FINDRISC-Br was formatted and minor spelling and grammatical errors cor-
rected. Further to this, the permission was asked from the Finnish Diabetes Association to use 
their layout of  the FINDRISC questionnaire, which was adopted for FINDRISC-Br (Figure 2).
Step 8: final report
Detailed description of  all steps and decisions taken as part of  the translation and cross-cul-
tural adaptation process for FINDRISC, thus recording the development of  the whole process.
ASSESSMENT OF TEST-RETEST RELIABILITY
A non-random sample of  105 people from the primary care health center was initially 
enrolled to assess test-retest reliability. Twenty-two of  them missed the two-week evaluation 
(retest), resulting in 83 individuals with test and retest. Reasons for missing retest were: health 
problems (n = 4), occupational commitments (n = 2), refusals (n = 3), and failure to reach 
the participant (n = 13). No statistical differences were found in baseline FINDRISC-Br scores 
between participants and non-participants in the re-examination (chi-square test, p > 0.05). 
A descriptive analysis of  the first interviews (n = 83) is presented in Table 1. The sample was 
mainly composed by women (74.7%), mean age of  52.3 years (standard deviation = 16.4 years). 
Almost 40% of  subjects scored ≥ 15 on the FINDRISC-Br questionnaire (Table 1). 
The test and retest agreement levels are shown in Table 2. Although some items of  the 
questionnaire presented coefficients lower than 0.8, the questionnaire as a whole presented 
high reliability (Cohen’s kappa = 0.82, 95%CI 0.72 – 0.92 and ICC = 0.94, 95%CI 0.91 – 0.96).
BARIM, E.M. ET AL.
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Figure 2. Brazilian version of Finnish Diabetes Risk Score (FINDRISC) questionnaire.
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< 45 23 27.71
45–54 15 18.07
55–64 24 28.92
> 64 21 25.30
Body-mass index (kg/m2)
< 25 17 20.48
25–30 34 40.96
> 30 32 38.55
Waist circumference (cm)
Man < 94, woman < 80 10 12.05
Man 94–102, woman 80–88 15 18.07
Man > 102, woman > 88 58 69.88
Physical activity ≥ 30 min/day
Yes 59 71.08
No 24 28.92
Daily consumption of fruit and vegetables
Every day 66 79.52
Not every day 17 20.48
Personal history of use of antihypertensive drugs
No 44 53.01
Yes 39 46.99
Personal history of hyperglycemia
No 67 80.72
Yes 16 19.28
Family history of diabetes
No 31 37.35
Yes: grandparent, aunt, uncle or first cousin 15 18.07
Yes: parent, brother, sister or own child 37 44.58
FINDRISC score




> 20   4   4.81
FINDRISC: Finnish Diabetes Risk Score.
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DISCUSSION
This paper provides the first official Brazilian Portuguese version of  FINDRISC in align-
ment with ISPOR guidelines. In the past, translation and cross-cultural adaptation of  such 
tools amounted to be a simple translation or, at best, performing comparisons between the 
original tool and its back-translation28. The ISPOR guidelines were developed to reduce 
the heterogeneity of  methods. These guidelines have been used extensively to translate and 
adapt health questionnaires in Brazil29-32 and across the world33,34.
The present translation and cultural adaptation of  FINDRISC took place without unex-
pected difficulties. Question number 5, which refers to the consumption of  fruits, vegeta-
bles, and berries in the original version, needed to be adapted and the term “berries” was 
dropped in line with Brazilian culture and commonly available varieties of  food in the 
country. The assessment of  test-retest reliability of  FINDRISC-Br showed Cohen’s kappa 
and ICC values higher than 0.8 for the questionnaire as a whole, showing adequate reliabil-
ity. However, the level of  agreement was below 0.8 for two questions: physical activity and 
consumption of  fruits and vegetables. We believe that these two questions were those most 
sensitive in the questionnaire since participants might have changed their answer at retest 
due to social desirability bias. This bias, well known in epidemiology, regards participants 
either denying undesirable characteristics or attributing themselves desirable characteristics35. 
The FINDRISC questionnaire was originally developed as a tool to predict T2DM in 
Finland1. Nowadays it is used around the world3,8,36, being easy to use, quick to apply, non-in-
vasive, and low-cost. FINDRISC has also become useful to screen T2DM in populations pre-
viously not known to have T2DM11,12. FINDRISC-Br could be used in Brazil in, either way, 
Table 2. Test-retest agreement levels for the Brazilian version of the Finnish Diabetes Risk Score 
(FINDRISC-Br) items in terms of Cohen’s kappa coefficients and intraclass correlation coefficients 
(ICC) with the corresponding 95% confidence intervals (95%CI).
FINDRISC variables Kappa (95%CI) ICC (95%CI)
Age (years) 0.97 (0.92 – 1.00) 0.96 (0.94 – 0.98)
Body-mass index (kg/m2) 0.92 (0.85 – 0.99) 0.96 (0.93 – 0.97)
Waist circumference (cm) 0.93 (0.86 – 0.99) 0.95 (0.93 – 0.97)
Physical activity ≥ 30 min/day 0.79 (0.64 – 0.94) 0.79 (0.69 – 0.86)
Daily consumption of fruit and vegetables 0.63 (0.41 – 0.84) 0.63 (0.48 – 0.74)
Personal history of use of antihypertensive drugs 0.93 (0.85 – 1.00) 0.93 (0.89 – 0.95)
Personal history of hyperglycemia 0.96 (0.88 – 1.00) 0.96 (0.94 – 0.98)
Family history of diabetes 0.87 (0.77 – 0.96) 0.88 (0.82 – 0.92)
FINDRISC total score 0.82 (0.72 – 0.92) 0.94 (0.91 – 0.96)
TRANSLATION AND ADAPTATION OF FINSRISC FORM
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to predict T2DM prospectively and to screen for previously undiagnosed T2DM. T2DM is 
a public health problem in Brazil, where almost half  of  people with diabetes are unaware 
of  their condition37. Since T2DM is mostly asymptomatic during the first years of  the dis-
ease onset, screening with a simple and inexpensive tool such as FINDRISC-Br is warranted. 
This study may present some limitations. First, we did not validate FINDRISC-Br and 
therefore do not know yet the cut-off  values for our population. Second, we used a non-ran-
dom sample, which could bias the scores we found. 
CONCLUSION
FINDRISC was translated into Brazilian Portuguese and culturally adapted following 
standard procedures, thus producing FINDRISC-Br. Validation is still needed, but already 
in the meantime, we believe that FINDRISC-Br has good potential as a reliable screening 
tool in different Brazilian settings and applications.
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